MeiraGTx Holdings (MGTX) Interest Coverage Ratio (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Interest Coverage Ratio came in at 4.65 in Q4 2025, up 140.41% YoY from 1.93 in Q4 2024, and up 130.95% on a QoQ basis from 15.02 in Q3 2025.
MeiraGTx Holdings (MGTX) Interest Coverage Ratio (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Interest Coverage Ratio data on file, last reported at 4.65 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 140.41% year-over-year to 4.65 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 8.36 (up 36.68% YoY) and the FY2025 annual result came in at 0.65, up 40.57% from the prior year.
- Interest Coverage Ratio advanced to 4.65 in Q4 2025, from 15.02 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 4.65 in Q4 2025 to a low of 64.62 in Q4 2021.
- A 5-year average of 15.25 and a median of 13.59 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio slumped 3470.37% — and 2025, when it jumped 140.41%.
- Tracing MGTX's Interest Coverage Ratio over 5 years: stood at 64.62 in 2021, then surged by 52.59% to 30.64 in 2022, then surged by 109.3% to 2.85 in 2023, then plunged by 504.07% to 11.51 in 2024, then jumped by 140.41% to 4.65 in 2025.
- The last three Interest Coverage Ratio figures came in at 4.65 (Q4 2025), 15.02 (Q3 2025), and 12.79 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 9.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.65 |
| Sep 30, 2025 | -15.02 |
| Jun 30, 2025 | -12.79 |
| Mar 31, 2025 | -4.64 |
| Dec 31, 2024 | -11.51 |
| Sep 30, 2024 | -11.72 |
| Jun 30, 2024 | -14.94 |
| Mar 31, 2024 | -14.39 |
| Dec 31, 2023 | 2.85 |
| Sep 30, 2023 | -9.69 |
| Jun 30, 2023 | -8.58 |
| Mar 31, 2023 | -10.38 |
| Dec 31, 2022 | -30.64 |
| Sep 30, 2022 | -12.05 |
| Jun 30, 2022 | -17.41 |
| Mar 31, 2022 | -20.97 |
| Dec 31, 2021 | -64.62 |
| Sep 30, 2021 | -18.28 |
| Jun 30, 2021 | -16.28 |
| Mar 31, 2021 | -18.58 |